FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2516274476> ?p ?o ?g. }

• W2516274476 endingPage "71" @default.
• W2516274476 startingPage "59" @default.
• W2516274476 abstract "Myxoma virus therapy of human embryonal rhabdomyosarcoma in a nude mouse model Veronica G Kinn, Valerie A Hilgenberg, Amy L MacNeill Department of Microbiology, Immunology and Pathology, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO, USA Abstract: Rhabdomyosarcoma (RMS) is a devastating tumor of young people that is difficult to cure. To determine if oncolytic virus therapy can improve outcomes in individuals with RMS, myxoma virus expressing a red fluorescent protein (MYXV-red) was evaluated for antitumoral effects using a murine model of RMS. Fluorescent protein was expressed in four RMS cell lines inoculated with MYXV-red, indicating that these cells were semipermissive to MYXV infection. MYXV-red replication and cytopathic effects were further evaluated using human embryonal RMS (CCL-136) cells. Logarithmic growth of MYXV-red and significant cell death were observed 72 hours after inoculation with MYXV. The oncolytic effects of MYXV-red were then studied in nude mice that were injected subcutaneously with CCL-136 cells to establish RMS xenografts. Once tumors measured 5 mm in diameter, mice were treated with multiple intratumoral injections of MXYV-red or saline. The average final tumor volume and rate of tumor growth were significantly decreased, and median survival time was significantly increased in MYXV-red-treated mice (P-values =0.0416, 0.0037, and 0.0004, respectively). Histologic sections of MYXV-red-treated tumors showed increased inflammation compared to saline-treated tumors (P-value =0.0002). In conclusion, MXYV-red treatment of RMS tumors was successful in individual mice as it resulted in decreased tumor burden in eight of eleven mice with nearly complete tumor remission in five of eleven mice. These data hold promise that MYXV-red treatment may be beneficial for people suffering from RMS. To our knowledge, this is the first report of successful treatment of RMS tumors using an oncolytic poxvirus. Keywords: poxvirus, myxoma virus, oncolytic virus, rhabdomyosarcoma" @default.
• W2516274476 created "2016-09-16" @default.
• W2516274476 creator A5046155143 @default.
• W2516274476 creator A5073804414 @default.
• W2516274476 creator A5081459525 @default.
• W2516274476 date "2016-08-01" @default.
• W2516274476 modified "2023-10-14" @default.
• W2516274476 title "Myxoma virus therapy of human embryonal rhabdomyosarcoma in a nude mouse model" @default.
• W2516274476 cites W1549834337 @default.
• W2516274476 cites W172838119 @default.
• W2516274476 cites W1978558644 @default.
• W2516274476 cites W1979631368 @default.
• W2516274476 cites W1984628239 @default.
• W2516274476 cites W1993591401 @default.
• W2516274476 cites W1993949716 @default.
• W2516274476 cites W2000678061 @default.
• W2516274476 cites W2013650858 @default.
• W2516274476 cites W2026721456 @default.
• W2516274476 cites W2027219473 @default.
• W2516274476 cites W2034386772 @default.
• W2516274476 cites W2039379299 @default.
• W2516274476 cites W2042608043 @default.
• W2516274476 cites W2057519757 @default.
• W2516274476 cites W2059782190 @default.
• W2516274476 cites W2062368814 @default.
• W2516274476 cites W2062490338 @default.
• W2516274476 cites W2071160772 @default.
• W2516274476 cites W2081804440 @default.
• W2516274476 cites W2081994579 @default.
• W2516274476 cites W2090992543 @default.
• W2516274476 cites W2092946093 @default.
• W2516274476 cites W2095076526 @default.
• W2516274476 cites W2109215820 @default.
• W2516274476 cites W2112979582 @default.
• W2516274476 cites W2119137829 @default.
• W2516274476 cites W212373775 @default.
• W2516274476 cites W2131132108 @default.
• W2516274476 cites W2134045444 @default.
• W2516274476 cites W2134499341 @default.
• W2516274476 cites W2138694950 @default.
• W2516274476 cites W2143809134 @default.
• W2516274476 cites W2146354379 @default.
• W2516274476 cites W2149140088 @default.
• W2516274476 cites W2155127143 @default.
• W2516274476 cites W2164893216 @default.
• W2516274476 cites W2181588388 @default.
• W2516274476 cites W2193922054 @default.
• W2516274476 doi "https://doi.org/10.2147/ov.s108831" @default.
• W2516274476 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4996258" @default.
• W2516274476 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27579297" @default.
• W2516274476 hasPublicationYear "2016" @default.
• W2516274476 type Work @default.
• W2516274476 sameAs 2516274476 @default.
• W2516274476 citedByCount "10" @default.
• W2516274476 countsByYear W25162744762018 @default.
• W2516274476 countsByYear W25162744762019 @default.
• W2516274476 countsByYear W25162744762020 @default.
• W2516274476 countsByYear W25162744762023 @default.
• W2516274476 crossrefType "journal-article" @default.
• W2516274476 hasAuthorship W2516274476A5046155143 @default.
• W2516274476 hasAuthorship W2516274476A5073804414 @default.
• W2516274476 hasAuthorship W2516274476A5081459525 @default.
• W2516274476 hasBestOaLocation W25162744761 @default.
• W2516274476 hasConcept C142724271 @default.
• W2516274476 hasConcept C159047783 @default.
• W2516274476 hasConcept C180032290 @default.
• W2516274476 hasConcept C2522874641 @default.
• W2516274476 hasConcept C2775996393 @default.
• W2516274476 hasConcept C2778256501 @default.
• W2516274476 hasConcept C2779745803 @default.
• W2516274476 hasConcept C2780844630 @default.
• W2516274476 hasConcept C71924100 @default.
• W2516274476 hasConcept C82210918 @default.
• W2516274476 hasConcept C86803240 @default.
• W2516274476 hasConceptScore W2516274476C142724271 @default.
• W2516274476 hasConceptScore W2516274476C159047783 @default.
• W2516274476 hasConceptScore W2516274476C180032290 @default.
• W2516274476 hasConceptScore W2516274476C2522874641 @default.
• W2516274476 hasConceptScore W2516274476C2775996393 @default.
• W2516274476 hasConceptScore W2516274476C2778256501 @default.
• W2516274476 hasConceptScore W2516274476C2779745803 @default.
• W2516274476 hasConceptScore W2516274476C2780844630 @default.
• W2516274476 hasConceptScore W2516274476C71924100 @default.
• W2516274476 hasConceptScore W2516274476C82210918 @default.
• W2516274476 hasConceptScore W2516274476C86803240 @default.
• W2516274476 hasLocation W25162744761 @default.
• W2516274476 hasLocation W25162744762 @default.
• W2516274476 hasLocation W25162744763 @default.
• W2516274476 hasLocation W25162744764 @default.
• W2516274476 hasOpenAccess W2516274476 @default.
• W2516274476 hasPrimaryLocation W25162744761 @default.
• W2516274476 hasRelatedWork W1981580506 @default.
• W2516274476 hasRelatedWork W1993591401 @default.
• W2516274476 hasRelatedWork W2025897640 @default.
• W2516274476 hasRelatedWork W2039333117 @default.
• W2516274476 hasRelatedWork W2081689148 @default.
• W2516274476 hasRelatedWork W2134045444 @default.
• W2516274476 hasRelatedWork W2338633568 @default.

• next